Dr. Rodriguez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5439 Ray Ellison Blvd
San Antonio, TX 78242
Summary
- Dr. Maria Rodriguez is a pediatrician in San Antonio, TX.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1986
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1979 - 1982
McGovern Medical School at UTHealthClass of 1979
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
TX State Medical License 2013 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial.Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, Penny Q Fang, Susan Y Wu
JAMA Oncology. 2024-09-01 - 3 citationsResponse-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial.Jillian R Gunther, Jie Xu, Manoop S Bhutani, Paolo Strati, Penny Q Fang
The Lancet. Haematology. 2024-07-01 - 1 citationsReal-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.Omar Mamlouk, Paolo Strati, Lei Feng, Ryan Sun, Amy Ayers
British Journal of Haematology. 2024-01-01
Abstracts/Posters
- Results of a Phase II Study of Obinutuzumab in Combination with Lenalidomide in Previously Untreated, High Tumor Burden Follicular Lymphoma (FL)Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System LymphomaMaria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
